🔎 Trials Near Me

Akèy › Kansè Metastatik › New York › Rochester

Etid klinik pou Kansè Metastatik nan Rochester, NY

8 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of ASP3082 in Adults With Advanced Solid Tumors

Ap rekriteFaz 1
  • University of Rochester Medical Center James P. Wilmot Cancer Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • Wilmot Cancer Institute, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • University of Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • University of Rochester - Wilmot Cancer Institute, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Ap rekriteFaz 2
  • Research Site, Rochester
Laj 18 a 130 · Tout sèks · Mizajou Aug 18, 2026 · NCT06792695

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Ap rekriteFaz 3
  • University of Rochester Medical Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06216301

Etid Kansè Metastatik nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.